Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,272 | 42 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $467.08 | 26 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $142.41 | 2 | $0 (2024) |
| Amgen Inc. | $125.00 | 1 | $0 (2020) |
| Boston Scientific Corporation | $125.00 | 1 | $0 (2019) |
| PFIZER INC. | $120.36 | 1 | $0 (2017) |
| Merz Pharmaceuticals, LLC | $114.68 | 3 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $89.06 | 4 | $0 (2022) |
| TRICE MEDICAL, INC. | $37.31 | 1 | $0 (2024) |
| Medtronic, Inc. | $19.47 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $18.58 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $553.82 | 19 | ABBVIE INC. ($281.00) |
| 2023 | $209.80 | 13 | AbbVie Inc. ($168.75) |
| 2022 | $119.61 | 6 | Ipsen Biopharmaceuticals, Inc ($89.06) |
| 2020 | $125.00 | 1 | Amgen Inc. ($125.00) |
| 2019 | $125.00 | 1 | Boston Scientific Corporation ($125.00) |
| 2018 | $18.58 | 1 | AstraZeneca Pharmaceuticals LP ($18.58) |
| 2017 | $120.36 | 1 | PFIZER INC. ($120.36) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/12/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $41.12 | General |
| Category: Musculoskeletal | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/16/2024 | TRICE MEDICAL, INC. | — | Food and Beverage | Cash or cash equivalent | $37.31 | General |
| 09/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/30/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $39.02 | General |
| Category: Musculoskeletal | ||||||
| 07/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/21/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $34.54 | General |
| Category: Musculoskeletal | ||||||
| 05/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/22/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $120.83 | General |
| Category: PSYCHIATRY | ||||||
| 01/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/14/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.61 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/23/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/04/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/15/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/13/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 566 | 930 | $256,775 | $70,141 |
| 2022 | 14 | 749 | 1,300 | $242,845 | $81,922 |
| 2021 | 3 | 60 | 100 | $16,850 | $7,648 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 137 | 429 | $100,760 | $28,050 | 27.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 71 | 71 | $29,720 | $7,592 | 25.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 37 | 39 | $25,935 | $5,613 | 21.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $16,380 | $5,384 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 84 | $13,650 | $4,038 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 40 | $10,550 | $3,849 | 36.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 39 | 39 | $14,625 | $3,707 | 25.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 32 | 49 | $9,750 | $2,910 | 29.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 33 | 33 | $9,000 | $2,843 | 31.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 20 | 28 | $9,000 | $2,231 | 24.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 22 | $7,480 | $2,173 | 29.1% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 11 | 11 | $6,400 | $1,050 | 16.4% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 14 | 21 | $3,150 | $681.45 | 21.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 25 | $375.00 | $21.89 | 5.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 160 | 332 | $62,250 | $18,476 | 29.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 112 | 261 | $49,050 | $14,754 | 30.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 104 | 107 | $25,250 | $11,639 | 46.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 82 | $16,000 | $8,135 | 50.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 47 | 87 | $23,100 | $6,706 | 29.0% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 49 | 49 | $15,950 | $5,075 | 31.8% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 69 | 103 | $14,000 | $3,601 | 25.7% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 35 | 35 | $12,800 | $3,528 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 49 | $7,150 | $3,315 | 46.4% |
| 99304 | Initial nursing facility visit per day, typically 25 minutes | Facility | 2022 | 32 | 33 | $6,475 | $2,374 | 36.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $5,400 | $2,303 | 42.6% |
About Dr. Usman Ashraf, M.D
Dr. Usman Ashraf, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Ypsilanti, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2017. The National Provider Identifier (NPI) number assigned to this provider is 1528595378.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Usman Ashraf, M.D has received a total of $1,272 in payments from pharmaceutical and medical device companies, with $553.82 received in 2024. These payments were reported across 42 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,272).
As a Medicare-enrolled provider, Ashraf has provided services to 1,375 Medicare beneficiaries, totaling 2,330 services with total Medicare billing of $159,712. Data is available for 3 years (2021–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Physical Medicine & Rehabilitation
- Location Ypsilanti, MI
- Active Since 05/11/2017
- Last Updated 08/14/2023
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1528595378
Products in Payments
- BOTOX (Biological) $443.94
- Aimovig (Biological) $125.00
- WATCHMAN (Device) $125.00
- ABILIFY MAINTENA (Drug) $120.83
- EMBEDA (Drug) $120.36
- Xeomin (Biological) $114.68
- DYSPORT (Drug) $89.06
- UBRELVY (Drug) $23.14
- REXULTI (Drug) $21.58
- SYNCHROMEDII (Device) $19.47
- SYMBICORT (Drug) $18.58
- Seglentis (Drug) $13.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Ypsilanti
Dr. Jennifer Doble, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $17,442
Ari Kriswari, Md, MD
Physical Medicine & Rehabilitation — Payments: $3,790
Dr. Marc Strickler, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $3,063
Dr. Jon Wardner, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $2,918
Ann Pattock, Pa-C, PA-C
Physical Medicine & Rehabilitation — Payments: $1,541
Dr. Stephen Bloom, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $1,536